1. Home
  2. NHTC vs OTLK Comparison

NHTC vs OTLK Comparison

Compare NHTC & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Health Trends Corp.

NHTC

Natural Health Trends Corp.

HOLD

Current Price

$3.35

Market Cap

37.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo Outlook Therapeutics Inc.

OTLK

Outlook Therapeutics Inc.

HOLD

Current Price

$0.45

Market Cap

38.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHTC
OTLK
Founded
1988
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
38.7M
IPO Year
1999
2016

Fundamental Metrics

Financial Performance
Metric
NHTC
OTLK
Price
$3.35
$0.45
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$3.83
AVG Volume (30 Days)
29.5K
1.5M
Earning Date
05-06-2026
06-02-2026
Dividend Yield
12.05%
N/A
EPS Growth
N/A
55.91
EPS
N/A
N/A
Revenue
$39,776,000.00
$8,146,123.00
Revenue This Year
N/A
$1,425.11
Revenue Next Year
N/A
$129.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$0.38
52 Week High
$5.48
$3.39

Technical Indicators

Market Signals
Indicator
NHTC
OTLK
Relative Strength Index (RSI) 40.29 39.72
Support Level $3.16 $0.39
Resistance Level $3.35 $0.53
Average True Range (ATR) 0.16 0.05
MACD -0.06 0.03
Stochastic Oscillator 13.58 43.78

Price Performance

Historical Comparison
NHTC
OTLK

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and support active, physical, and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and the rest from China, Taiwan, Japan, the United States, and other regions.

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Share on Social Networks: